Journal of Medical Economics
Volume 25, 2022 - Issue 1
Open access
4,803
Views
6
CrossRef citations to date
0
Altmetric
Diabetes
The PRIME Type 2 Diabetes Model: a novel, patient-level model for estimating long-term clinical and cost outcomes in patients with type 2 diabetes mellitus
Richard F. Pollocka Health Economics and Outcomes Research, Covalence Research Ltd, London, UK
https://orcid.org/0000-0002-9873-7507
Kirsi Norrbackab Eli Lilly Finland, Helsinki, Finland
, Kristina S. Boyec Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Indianapolis, USA
, Beatrice Osumilid GPORWE International, Eli Lilly and Company Ltd, Surrey, UK
https://orcid.org/0000-0002-5862-9325
William J. Valentinee Health Economics, Ossian Health Economics and Communications, Basel, SwitzerlandCorrespondence[email protected]
Pages 393-402
|
Received 27 Aug 2021, Accepted 25 Jan 2022, Published online: 21 Mar 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.